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The baculovirus Autographa californica nuclear polyhedrosis virus was used as an expression vector to
produce hepatitis B virus surface antigen with and without the pre-S domain. The S gene product was
expressed as both fusion and nonfusion polypeptides. No difference was observed in the posttranslational
modification of the fusion and nonfusion polypeptides. The S proteins were not secreted into the medium but
were inserted into the endoplasmic reticulum, glycosylated, and partially extruded into the lumen of the
endoplasmic reticulum as 22-nm lipoprotein particles. The oligosaccharide chains on the insect cell-derived S
protein were of the N-linked high-mannose form, in contrast to the complex-type oligosaccharides detected on
plasma-derived hepatitis B virus surface antigen. The pre-S-S polypeptides were inserted into the endoplasmic
reticulum, glycosylated, and modified by fatty acid acylation with myristic acid. A procedure was developed to
purify the S protein from cellular membranes by using detergent extraction and immunoaffinity chromatog-
raphy. The purified S protein was in the form of protein-detergent micelles and was highly antigenic and
immunogenic.
A variety of systems have been developed for expression
of large quantities of mammalian proteins, including bacte-
rial, yeast, and mammalian cells. Recently, the baculovirus
Autographa californica nuclear polyhedrosis virus (AcNPV)
has been used successfully as a helper-independent expres-
sion vector (55). Foreign genes are expressed under the
control of the very strong promoter of the polyhedrin gene
(15). Insect cells appear to provide proper processing of
mammalian proteins, including secretion (48, 49), glycosyl-
ation (7, 22, 49), and nuclear translocation (18, 23, 33), as
well as a number of other modifications (reviewed in refer-
ence 28). However, many of the proteins that have been
expressed in baculovirus either did not require complex
posttranslational modifications or were not extensively char-
acterized. This investigation was undertaken as a model
system to examine the capacity of insect cells to perform a
series of complex modifications on a mammalian protein, the
hepatitis B virus (HBV) surface antigen (HBsAg).
The mature HBV virion is composed of a proteinaceous
lipid envelope and an inner icosahedral nucleocapsid that
contains the partially double-stranded circular DNA ge-
nome, a virion polymerase, and a protein covalently bound
to the viral DNA (9, 10, 56). The lipid envelope contains the
surface antigen (HBsAg) that is also expressed independent
of the virion as spherical and filamentous lipoprotein parti-
cles with a diameter of approximately 20 nm (42) and is
present at high concentrations in the serum of infected
individuals. Three partially homologous HBsAg polypep-
tides are expressed by utilizing three different mRNAs and
three in-phase ATG initiation codons (2, 12, 44, 51). The S
gene encodes the major HBsAg polypeptide, which is 226
amino acids in length. The pres-S2 domain adds an amino-
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terminal extension of 55 amino acids to the S polypeptide,
and the pre-S, region extends the polypeptide and additional
108 to 119 amino acids, depending on the subtype. The S and
pre-S, polypeptides exist in both glycosylated and unglyco-
sylated forms, while the pre-S2 polypeptide can be glycosy-
lated at one or two sites (12, 41, 53, 54). The pre-S,
polypeptide inhibits the secretion of HBsAg particles (3, 4,
31, 35, 39, 50), a property which may be related to its
modification by fatty acid acylation with myristic acid (40)
and may play a role in virion assembly.
In this investigation, recombinant baculoviruses were
isolated that express HBsAg with and without the pre-S
domain. HBsAg synthesized in insect cells was glycosylated
and partially assembled into lipoprotein particles but was not
efficiently secreted. The pre-S, polypeptide was both glyco-
sylated and myristylated. A procedure for the purification of
highly antigenic HBsAg from insect cells is described.
MATERIALS AND METHODS
Cells and viruses. The continuous insect cell line Sf9 was
derived from Spodoptera frugiperda (fall armyworm) (54)
and was maintained in TNM-FH medium (13) containing
10% fetal bovine serum. The growth, purification, and assay
of AcNPV have been described previously (58, 59). Detailed
procedures for the use of AcNPV as a recombinant expres-
sion vector system have been published in a manual de-
signed for this purpose (54).
Construction of plasmids. The baculovirus plasmid transfer
vectors pAc373 and pVL106 (28) were used in this investi-
gation. Both plasmids contain the pUC8 plasmid with an
insert of the polyhedrin-encoding sequences flanked by
several kilobases of AcNPV sequences 3' and 5' of the
polyhedrin gene (Fig. 1). The sequences encoding the S gene
were obtained by digestion of pN-3 (26) with FnudII (nucle-
otides 131 to 1356), and the sequences encoding the pre-S-S
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FIG. 1. Structure and partial nucleotide sequence of baculovirus transfer vector and HBV DNAs. (A) Circular map of the baculovirus
transfer vectors pAc373 and pVL106. The thick lines represent the 5' and 3' sequences flanking the polyhedrin gene, which is represented
by the hatched area. The vectors contain a unique BamHI site at -8 (pAc373) and +12 (pVL106) nucleotides with respect to the polyhedrin
ATG initiation codon. (B) Functional and structural map of the HBV genome. The positions of the open reading frames encoding the pre-S1,
pre-S2, and S genes are depicted, as are the restriction endonuclease cleavage sites used to obtain DNA fragments encoding the S gene
(FnudII) and the pre-S-S gene (BstEII and Hpal). (C) Partial nucleotide sequences of AcNPV DNA, the baculovirus transfer vector plasmids,
and recombinant plasmids containing the S and pre-S-S genes. The DNA sequence of AcNPV surrounding the polyhedrin initiation codon is
compared with the sequences in the baculovirus transfer vector plasmids pAc373 and pVL106 up to the BamHI site used for inserting foreign
genes.
gene were derived by digestion of pN-5 with BstEII and
HpaI (nucleotides 2824 to 966). Single-stranded termini were
filled in by reaction with the Klenow fragment of DNA
polymerase I, and the internal BamHI site in the pre-S-S
gene was protected by treatment with BamHI methylase.
BamHI linkers were added by blunt-end ligation, the linkers
were digested with BamHI, and the resulting fragments were
cloned into BamHI-digested, alkaline phosphatase-treated
pAc373 or pVL106.
Analysis of proteins by SDS-PAGE and immunoblot. In-
fected Sf9 cells were washed three times in phosphate-
buffered saline (PBS), and cellular proteins were solubilized
in detergent extraction buffer (50 mM Tris hydrochloride
[pH 9.0], 100 mM NaCl, and 1% Nonidet P-40 [NP-40]). In
some experiments, cells were divided into soluble and par-
ticulate fractions by sonication in PBS and centrifugation at
3,000 x g for 20 min prior to detergent extraction. Medium
from infected cultures was clarified at 3,000 x g for 10 min
and adjusted to 1% NP-40. Samples for sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
were disrupted in electrophoresis sample buffer containing
2% SDS and 2% 2-mercaptoethanol and heated at 100°C for
5 min. Proteins were separated by SDS-PAGE as described
previously (24) and either silver-stained, autoradiographed,
or processed for the immunoblot procedure with rabbit
antiserum to HBsAg and 125I-protein A (New England
Nuclear).
Analysis of HBsAg on CsCl gradients. Sf9 cells were
infected with the recombinant virus 106FS and harvested for
HBsAg purification at 72 h postinfection. Cells were washed
three times in PBS and lysed by sonication in PBS. The
cellular lysate was clarified, and HBsAg was pelleted by
ultracentrifugation for 70 min at 435,000 x g (TL-100 ultra-
centrifuge; Beckman). The pellet was suspended in PBS and
loaded onto a discontinuous CsCl gradient (1.10 to 1.40
g/cm3). Equilibrium sedimentation of HBsAg was performed
by ultracentrifugation for 24 h at 36,000 rpm in an SW41
rotor (Beckman). Fractions (0.5 ml) were collected from the
bottom, diluted 10,000-fold, and assayed for HBsAg content
by AUSRIA II (Abbott). HBsAg in the peak fraction was
examined by electron microscopy following negative stain-
ing with phosphotungstic acid.
ConA-agarose chromatography. Sf9 cells infected with the
373S recombinant virus were detergent extracted at 48 h
postinfection as described above. The extracts were incu-
bated for 1 h at 37°C with 200 RI of concanavalin A
(ConA)-agarose beads (Bethesda Research Laboratories).
The supernatant containing unbound proteins was saved for
analysis, and unglycosylated HBsAg bound to the resin due
to interchain disulfide bonds with glycosylated HBsAg was
eluted with 10 mM dithiothreitol. The resin was washed
three times with detergent extraction buffer, and bound
proteins were eluted with 1 M ot-methyl-D-mannoside in 0.1
M borate buffer (pH 6.5) containing 1% NP-40. A portion of
each fraction was analyzed by SDS-PAGE and immunoblot
as described above.
Glycosidase treatment. Sf9 cells were infected with the
373S recombinant baculovirus and pulse-labeled with 250
p.Ci of [35S]methionine per ml from 24 to 40 h postinfection.
Detergent extracts were prepared as described above, and
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HBsAg was immunoprecipitated with rabbit antiserum to
HBsAg and protein A-agarose beads. HBsAg was eluted
from the immune complexes by heating at 95°C for 2 min in
the presence of 0.5% SDS and 0.1 M 2-mercaptoethanol.
Equal portions of the eluate were used as an untreated
control or for digestion with endoglycosidase H (endo H)
(Genzyme Corp., Boston, Mass.). Samples were diluted
threefold in 50 mM sodium phosphate buffer (pH 5.7) in
order to reduce the concentration of SDS and 2-mercapto-
ethanol, incubated at 37°C for 6 h to permit enzyme diges-
tion, and analyzed by SDS-PAGE and autoradiography.
Analysis of fatty acid acylation. Sf9 cells infected with the
recombinant virus 373PS were labeled at 48 h postinfection
for 4 h with 25 ,uCi of [35S]methionine or 1 mCi of
[3H]myristic acid (New England Nuclear) per ml. Labeled
cells were detergent extracted, HBsAg was immunoprecip-
itated, and immunoprecipitates were analyzed by SDS-
PAGE, fluorography, and autoradiography.
HBsAg purification and analysis of antigenicity. Sf9 cells
infected with the 106FS recombinant virus were harvested at
48 h postinfection, washed three times with PBS, and
detergent extracted as described above. HBsAg was affinity
purified by a modification of a previously described method
(60). Affinity columns for the purification of HBsAg were
prepared with chimpanzee antiserum reactive with HBsAg.
The immunoglobulin G (IgG) fraction of the chimpanzee
serum was affinity purified on HBsAg covalently attached to
cyanogen bromide-activated Sepharose-4B (Pharmacia,
Inc., Piscataway, N.J.). The affinity-purified anti-HBsAg
IgG was covalently bound to protein A-agarose by using the
bifunctional cross-linking agent dimethyl pimelimidate (43).
Detergent extracts containing HBsAg were slowly passed
over the affinity resin for 2 h. The resin was washed
sequentially with PBS, 1 M NaCl, and PBS. HBsAg was
eluted with 3 M ammonium thiocyanate and dialyzed against
PBS. The amount of HBsAg polypeptide was quantitated on
silver-stained gels by comparison to a known standard of
HBsAg purified from human plasma.
RESULTS
Preparation of recombinant baculovirus. This investigation
used two different baculovirus transfer vectors for the iso-
lation of recombinant viruses expressing HBsAg. The
pAc373 vector contains a BamHI site at nucleotide -8 with
respect to the polyhedrin initiation codon (Fig. 1A and C).
Insertion of a foreign gene into this vector results in the
expression of a native protein. The pVL106 vector has a
BamHI site at nucleotide +12 in relation to the polyhedrin
ATG, so that insertion of a foreign gene into pVL106 results
in the synthesis of a fusion protein (Fig. 1A and C). The
intact 5' leader sequence of the polyhedrin gene in pVL106
results in the synthesis of higher levels of recombinant
protein than are obtained with pAc373 (25, 28).
HBV DNA fragments encoding HBsAg with and without
the pre-S region (Fig. 1B) were cloned into the baculovirus
transfer vectors as described in Materials and Methods.
Insertion of the S gene into pAc373 yielded a recombinant
transfer vector plasmid, designated p373S, while insertion of
the same sequences into pVL106 resulted in plO6FS, which
encodes a fusion protein with two amino acids derived from
polyhedrin, four amino acids encoded by linker sequences,
nine amino acids of the pre-S2 region, and the intact S
protein. A DNA fragment containing the entire pre-S-S gene
was cloned into pAc373 to obtain p373PS.
Sf9 cells were cotransfected with each of the recombinant
transfer vectors and AcNPV DNA. Homologous recombi-
nation between the AcNPV sequences present in the transfer
vectors and viral DNA gave rise to recombinant viruses that
were identified in plaque assays by their lack of polyhedrin
occlusions (54).
Expression of HBsAg. Sf9 cells infected with the recombi-
nant baculoviruses 373S, 106FS, and 373PS were examined
for the synthesis of HBsAg-related polypeptides at 48 h
postinfection. Cellular lysates were prepared with NP-40
extraction buffer and analyzed by SDS-PAGE and immuno-
blot as described under Materials and Methods. High levels
of HBsAg polypeptides were expressed following infection
of Sf9 cells with each of the recombinant viruses. 373S
induced the synthesis of two polypeptides corresponding in
molecular weight to the unglycosylated (p25) and glycosy-
lated (gp29) major HBsAg polypeptides. The fusion polypep-
tides encoded by 106FS had a discernible reduction in
mobility in SDS gels due to the 15 additional amino acids at
the amino terminus of the polypeptides and appeared to be
present in the glycosylated and unglycosylated forms as
well. 373PS induced the synthesis of two polypeptides with
apparent molecular weights of 39,000 and 42,000, suggesting
that they represented the unglycosylated and glycosylated
forms of the pre-S1-pre-S2-S polypeptide (p39 and gp42),
respectively (data not shown; see Fig. 3 for representative
polypeptides).
Secretion of HBsAg polypeptides was examined by using
clarified medium from the infected cultures for the immuno-
blot procedure. Cultures infected with the different recom-
binant viruses were harvested every day for 5 days postin-
fection. An equal fraction of the cellular extracts and the
medium corresponding to 2.5 x 104 cells were analyzed by
SDS-PAGE and immunoblot. The same results were ob-
tained with each of the recombinant viruses. The analysis of
373S-infected cultures is depicted in Fig. 2. Maximal levels
of intracellular p25 and gp29 were detected 2 to 3 days
postinfection. Thereafter, the level of intracellular HBsAg
remained constant, but at no time was significant HBsAg
detected in the medium.
The level of HBsAg synthesis for 373S, 106FS, and 373PS
was determined by comparison of cellular extracts to an
HBsAg standard of known concentration purified from hu-
man plasma. Cellular extracts were prepared from infected
cultures at 48 h postinfection by detergent extraction. Vari-
ous amounts of the extracts and the HBsAg standard were
compared by SDS-PAGE and immunoblot (data not shown).
The level of HBsAg synthesis was estimated at approxi-
mately 90 mg/liter for 106FS and 6 mg/liter for both 373S and
373PS. These estimates were extrapolated from the amount
of antigen derived from cultures grown in 25-cm2 flasks (4 x
106 cells) to a 1-liter spinner culture (2 x 109 cells).
Intracellular localization of HBsAg in Sf9 cells. The detec-
tion of potentially glycosylated forms of HBsAg (gp29 and
gp42) in cellular extracts suggested that insertion of the
polypeptides into the membrane of the endoplasmic reticu-
lum (ER) had occurred and that secretion of the S polypep-
tide was blocked at a subsequent step. Unfortunately, accu-
rate methods for fractionating insect cells into subcellular
fractions have not been developed. Since HBsAg still in
association with the ER should be insoluble in the absence of
detergent, and HBsAg in the form of a lipoprotein particle
should be soluble, cellular fractionation experiments were
performed in an attempt to determine whether the HBsAg
polypeptides were in a soluble or insoluble form within the
cell.
Sf9 cells were infected with 373S, 106FS, and 373PS
viruses and harvested 48 h postinfection. Medium was
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FIG. 2. Lack of secretion of HBsAg synthesized in insect cells.
Sf9 cells infected with 373S were harvested every day for 5 days
postinfection. The medium was clarified to remove cellular debris,
and a cellular extract was prepared by detergent extraction. An
equal fraction of the cell extracts and media were analyzed by
SDS-PAGE and immunoblot. HBsAg expression was first detected
in the cell extracts on day 2 and was approximately equal on days 3
to 5. HBsAg could not be detected in the medium at any time point.
The positions of p25 and gp29 from plasma-derived HBsAg are
depicted at the left.
clarified to remove cellular debris, and cells were fraction-
ated into soluble and particulate fractions by sonication and
centrifugation at 3,000 x g for 20 min. Equal portions of
medium and soluble and particulate cellular fractions were
analyzed by SDS-PAGE and immunoblot. The increased
level of HBsAg synthesis obtained with 106FS required that
the fractions analyzed for 373S and 373PS be derived from a
greater number of cells (2 x 105 cells) than the fractions
analyzed for 106FS-infected cultures (1 x 104 cells). The
pre-S-S polypeptides (p39 and gp42) encoded by 373PS were
localized almost exclusively to the particulate cellular frac-
tion (Fig. 3). The S polypeptides (p25 and gp29) expressed by
373S were distributed approximately equally between the
particulate and soluble fractions, whereas the fusion poly-
peptides derived from 106FS were predominantly localized
in the particulate fraction (Fig. 3). Both S and pre-S poly-
peptides were completely solubilized with 1% NP-40 (data
not shown), suggesting that HBsAg in the particulate frac-
tion was membrane found. The percentage of the fusion
polypeptides localized to the soluble fraction varied from
one experiment to another, with approximately 10 to 20% of
the antigen in the soluble fraction. Since a 20-fold greater
number of cells were analyzed for 373S than for 106FS, the
actual amount of HBsAg polypeptides in the soluble fraction
of 106FS-infected cells was greater than or equal to that
observed with 373S. These data suggest that formation of a
lipoprotein particle by budding of HBsAg into the lumen of
the ER may be a rate-limiting step in insect cells. The
restriction of p39 and gp42 to the particulate fraction (pre-
sumably ER) of insect cells is in agreement with previous
observations made with mammalian cells (3, 4, 31, 35, 39).
The assembly of HBsAg into lipoprotein particles in insect
cells infected with 106FS was investigated further by equi-
librium sedimentation in CsCl gradients and electron micros-
copy. Sf9 cells were harvested 3 days postinfection with
106FS, and a soluble cellular extract was prepared by
sonication in PBS and clarification. HBsAg was concen-
trated from the clarified extract by ultracentrifugation, and
the pellet was suspended and analyzed on a CsCl gradient as
described under Materials and Methods. Fractions were
collected from the bottom, diluted 10,000-fold, and assayed
for HBsAg content by AUSRIA II. Virtually all of the
soluble HBsAg activity pelleted in the first ultracentrifuga-
tion and banded at 1.19 g/cm3 in CsCI (Fig. 4A). Examination
of the peak fraction by electron microscopy revealed the
presence of lipoprotein particles with a diameter of 22.3 +
3.8 nm (Fig. 4B). These data indicate that the major HBsAg
polypeptide synthesized in insect cells is inserted into the
ER membrane and at least partially assembled into lipopro-
tein particles.
Glycosylation of HBsAg. The expression of two S polypep-
tides by recombinant viruses 373S and 106FS suggested that
the polypeptides represented the unglycosylated (p25) and
glycosylated (gp29) forms of the small HBsAg polypeptide.
However, for unknown reasons, in 373S-infected cells the
amount of gp29 in relation to p25 varied considerably be-
tween experiments (Fig. 2 and 3). The pre-S-S polypeptides
encoded by 373PS also had mobilities on SDS gels that
would correspond to the unglycosylated (p39) and glycosy-
lated (gp42) forms of this polypeptide. In order to directly
demonstrate the glycosylation of HBsAg in insect cells, the
polypeptides were examined for binding to the lectin ConA
and for alterations in mobility on SDS gels following treat-
ment with endoglygosidases. For lectin-binding experi-
ments, Sf9 cells were infected with the recombinant viruses
373S, 106FS, and 373PS, and detergent extracts were pre-
pared 48 h postinfection. The extracts were incubated with
ConA-agarose beads for 1 h at 37°C, the supernatants
containing the unbound proteins were removed, and the
resins were sequentially eluted with 10 mM dithiothreitol
and 1 M a-methyl-D-mannoside. Portions of each fraction
were analyzed by SDS-PAGE and immunoblot. The higher-
molecular-weight HBsAg polypeptide from 373S-infected
cells was quantitatively bound to the column and eluted with
the competing sugar (Fig. SA), indicating that it represented
glycosylated gp29. A portion of the unglycosylated p25 was
initially bound to the resin but could be eluted with dithio-
threitol, suggesting that it was bound to the column due to
interchain disulfide bonds with gp29. Similar results were
observed with 106FS- and 373PS-infected cells (data not
shown).
The binding of HBsAg polypeptides to ConA demon-
strated the presence of cx-mannose residues on gp29 and gp42
but did not indicate the type of carbohydrate structure
present on the polypeptides. Treatment with endo H was
Plasma 106FS 373S 373PS
HBSAgIMS PI iM S p11 M S P1
HBsAgF-S-_ s __PIms F
FIG. 3. Comparison of HBsAg synthesized by 373S, 106FS, and
373PS for secretion and solubility of intracellular HBsAg. Sf9 cells
were infected with the recombinant viruses 373S, 106FS, and 373PS
and harvested at 48 h postinfection. Media (M) were clarified to
remove cellular debris, and cellular extracts were divided into
soluble (S) and particulate (P) fractions by sonication in PBS and
centrifugation at 3,000 x g for 20 min. An equal portion of each
fraction was analyzed by SDS-PAGE and immunoblot, except that
20-fold fewer cells were used in the analysis of 106FS due to greater
levels of HBsAg synthesis obtained with this virus. Secretion of
HBsAg could not be detected in any of the cultures. The pre-S-S
polypeptides (p39 and gp42) were entirely within the particulate
fraction, while the nonfusion and fusion forms of the S polypeptides
(p25 and gp29) were partially soluble.
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FIG. 4. Assembly of intracellular HBsAg into lipoprotein parti-
cles. Sf9 cells infected with 106FS were harvested 48 h postinfec-
tion, and a soluble cellular extract was prepared by sonication in
PBS and centrifugation at 3,000 x g for 20 min. HBsAg was
concentrated from the soluble supernatant by ultracentrifugation,
and the pellet was analyzed on a CsCl gradient. Each fraction was
diluted 10,000-fold and assayed for HBsAg by AUSRIA II. The
HBsAg activity banded at a density of 1.19 g/cm3 (A), and exami-
nation of the peak fraction by electron microscopy revealed lipo-
protein particles with a diameter of 22 nm (B). Bar, 50 nm.
used to determine the type of oligosaccharides present on
gp29, since it removes oligosaccharides of the N-linked
high-mannose type (21). Sf9 cells were infected with 373S,
labeled with [35S]methionine for 12 h at 24 h postinfection,
and detergent extracted. HBsAg was immunoprecipitated
from extracts, eluted from the immune complexes with SDS
and 2-mercaptoethanol, and treated with endo H as de-
scribed under Materials and Methods. Treatment of HBsAg
derived from 373S-infected cell extracts with endo H re-
A.
E U D M
gp29- b _
p 25-
B.
C H
5s
FIG. 5. ConA chromatography and endoglycosidase treatment
of HBsAg. (A) Sf9 cells were infected with the recombinant virus
373S, and detergent extracts were prepared 48 h postinfection. The
starting extract (E) was incubated with ConA-agarose for 1 h at
37°C, the supernatant containing unbound proteins (U) was re-
moved, and the resin was sequentially eluted with 10 mM dithio-
threitol (D) and 1 M a-methyl-D-mannoside (M). A portion of each
fraction was analyzed by SDS-PAGE and immunoblot. The higher-
molecular-weight glycosylated polypeptide (gp29) was quantita-
tively bound by the resin. In addition, a portion of the unglycosy-
lated polypeptide (p25) was bound, presumably due to association
with the glycosylated polypeptides, and eluted with dithiothreitol.
(B) Sf9 cells were infected with the recombinant virus 373S, labeled
with [35S]methionine for 12 h at 24 h postinfection, and detergent
extracted. HBsAg was immunoprecipitated from the extracts,
eluted from the immune complexes with SDS and 2-mercaptoeth-
anol, and either treated with endo H (H) or left untreated as a
control (C). The samples were analyzed by SDS-PAGE and autora-
diography.
sulted in conversion of gp29 to p25, as determined by
comigration on SDS gels (Fig. SB). In contrast, the secreted
gp29 from plasma-derived HBsAg was endo H resistant and
N-glycanase sensitive (1) (data not shown). These results
demonstrate that HBsAg derived from insect cells is modi-
fied with N-linked high-mannose oligosaccharides, while
plasma-derived HBsAg possesses processed N-linked sac-
charides.
Myristylation of HBsAg. Recently, the modification of the
pre-S-S polypeptides of HBsAg by fatty acid acylation
(myristic acid) has been demonstrated in mammalian cells
(40). In order to determine whether insect cells were capable
of performing this modification of HBsAg, 373PS-infected
Sf9 cells were labeled with either [35S]methionine or
[3H]myristic acid from 44 to 48 h postinfection. HBsAg was
immunoprecipitated and examined by SDS-PAGE, fluorog-
raphy, and autoradiography. Both p39 and gp42 were effi-
ciently labeled with [35S]methionine and [3H]myristate (Fig.
6). Several control experiments were performed to demon-
strate the specificity of the labeling. Other cellular proteins
were not labeled during the myristic acid pulse, indicating
the lack of significant randomization of the isotope. The
pre-S polypeptides were not labeled during a pulse with
[3H]palmitic acid, and in the same experiments, simian virus
40 (SV40) T antigen was labeled with palmitic acid but not
myristic acid in Sf9 cells infected with a recombinant bacu-
lovirus encoding T antigen (23). These results indicate that
insect cells are capable of the efficient modification of
mammalian cell proteins by fatty acid acylation.
Antigenicity and immunogenicity of HBsAg. The lack of
HBsAg secretion and the relatively inefficient formation of
1.19//
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FIG. 6. Myristylation of the pre-S-S polypeptides. Sf9 cells
infected with 373PS were labeled with [35S]methionine (Met) or
[3H]myristic acid (Myr) for 4 h at 48 h postinfection and then
detergent extracted. HBsAg was immunoprecipitated and examined
by SDS-PAGE, fluorography, and autoradiography. The positions
of molecular weight standards (M) are shown (in thousands) at the
left. The pre-S-S polypeptide was efficiently labeled with both
methionine and myristic acid.
HBsAg lipoprotein particles by insect cells dictated that a
purification procedure other than CsCl gradients be used.
The efficient detergent solibilization of HBsAg from 106FS-
infected cells and previous reports that HBsAg detergent
micelles were highly antigenic (16, 46, 47) suggested that
affinity purification of detergent-extracted HBsAg might
yield a suitable antigen. To this end, Sf9 cells infected with
106FS were extracted 48 h postinfection with PBS contain-
ing 1% NP-40 and the HBsAg was affinity purified as
described in Materials and Methods. Analysis of the cellular
extract and the purified HBsAg by SDS-PAGE and silver
staining demonstrated that p25 and gp29 had been purified to
near homogeneity (Fig. 7). Examination of the preparation
by electron microscopy confirmed the presence of micelles
with diameters ranging from 20 to 50 nm.
The antigenicity of the purified recombinant HBsAg was
examined by comparison with plasma-derived HBsAg in a
commercial enzyme-linked immunosorbent assay (NML
[HBsAg] ELISA; Organon Teknika Corporation; Nuclear
Medical Laboratories). Prior to assay, the concentration of
the recombinant HBsAg was determined by comparison to a
known standard of HBsAg purified from human plasma by
SDS-PAGE and silver staining. The two preparations could
not be compared by absorbance at 280 nm, since one was a
detergent micelle and the other was a lipoprotein particle.
The two forms of HBsAg were compared in the ELISA at
concentrations ranging from 0.05 to 100 ng per assay. Both
antigens yielded positive reactions at all concentrations
above 3 ng per assay (Fig. 7). The reactivity of the recom-
binant HBsAg in the ELISA was approximately equivalent
to that of the plasma-derived HBsAg, indicating that a highly
antigenic form of HBsAg can be purified to near homogene-
ity in large quantities from insect cells infected with recom-
binant baculoviruses. In addition, the immunogenicity of
insect cell-derived HBsAg was examined in BALB/c mice.
Five mice were immunized intraperitoneally with two injec-
tions (5 jig each) of alum-precipitated HBsAg (20) at a
2-week interval. Serum was obtained 14 to 21 days following
the second immunization, and the anti-HBsAg response was
determined in a solid-phase ELISA that used a solid-phase
coat of insect cell-derived HBsAg. The results demonstrated
that HBsAg purified from insect cells can induce a vigorous
in vivo anti-HBsAg response in mice (mean titer, 20,000).
0.8 0.2 0.05
HBSAg (ng)
FIG. 7. Antigenicity of HBsAg. Insect-derived HBsAg was pu-
rified from Sf9 cells infected with 106FS by detergent extraction and
immunoaffinity purification. Inset: SDS-PAGE silver-staining pat-
tern for the total cellular extract (A) and the immunoaffinity-purified
HBsAg (B). The insect-derived material was quantitated by com-
parison to a known standard of plasma-derived HBsAg by SDS-
PAGE and silver staining. The plasma HBsAg (0) and the 106FS
HBsAg (AL) were compared for reactivity in a commercial ELISA
for HBsAg (Organon Teknika Corporation; Nuclear Medical Labo-
ratories). The insect-derived material was approximately twofold
less reactive than the plasma-derived HBsAg. Both antigens were
reactive in the assay at all concentrations greater than 3 ng per
assay.
DISCUSSION
The synthesis, assembly, modification, and secretion of
HBsAg lipoprotein particles by mammalian cells represent a
complex series of posttranslational modifications. Bacterial
and yeast expression systems are not capable of properly
processing HBsAg. The use of the baculovirus AcNPV as an
expression vector system has recently found widespread
acceptance (28, 49, 54). Proper posttranslational modifica-
tion has been demonstrated for many of the proteins ex-
pressed in insect cells (reviewed in reference 28). However,
most of the mammalian proteins synthesized in insect cells
have not been extensively characterized or do not normally
require a series of complex processing steps. This investiga-
tion was performed to examine the fidelity of modification of
highly complex mammalian proteins by insect cells as a
model system. No difference in modification was observed
between fusion and nonfusion forms of HBsAg. Both forms
of the S protein were inserted into the ER, partially modified
by glycosylation, complexed by interprotein disulfide bonds,
and partially extruded into the lumen of the ER as lipopro-
tein particles. Significant levels of HBsAg were not detected
in the medium. Production of intracellular lipoprotein parti-
cles was confirmed by purification on CsCl gradients.
HBsAg reactivity banded at a density of 1.19 g/ml, and
electron microscopy documented the presence of particles
with a diameter of approximately 22 nm. Cellular fractiona-
tion experiments demonstrated that a large percentage of the
HBsAg polypeptides were in a particulate fraction. The
solubility of the HBsAg in the particulate fraction with
nonionic detergents suggested that the polypeptides were
membrane associated (presumably in the ER). Sophisticated
procedures for ER membrane purification have not been
developed for insect cells. However, endoglycosidase treat-
ments also suggested that HBsAg lipoprotein particles were
in the ER due to the presence of N-linked high-mannose
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oligosaccharide chains. In mammalian cells, N-linked high-
mannose oligosaccharides are present within the ER, but
these structures are generally processed to a complex oli-
gosaccharide structure following the transition of the poly-
peptide from the ER to the Golgi as part of the pathway for
secretion (8, 27). Although insect cells do not modify N-
linked oligosaccharide side chains to the complex form, they
are capable of trimming high-mannose side chains to a
trimannosyl core (17). HBsAg synthesized in Sf9 cells had
not been processed to the trimannosyl core stage, since this
structure is endo H resistant (21). Recently, a defect in the
processing of oligosaccharide chains on the epidermal
growth factor receptor in Sf9 cells was observed, even
though the epidermal growth factor receptor was transported
to the cell surface (11). Due to the lack of HBsAg secretion
in insect cells, it was not possible to evaluate the ability of
insect cells to process the carbohydrate side chains.
Two steps in HBsAg secretion appeared to be blocked in
insect cells, both of which involved the processing of a
lipoprotein particle. The first step was the efficient formation
of HBsAg particles. Although this is a highly specialized
process, HBsAg lipoprotein particles are produced and
secreted by a number of undifferentiated mammalian tissue
culture cell lines. The fact that insect cells were capable of
modifying a major percentage of HBsAg into lipoprotein
particles indicates that the cells are not totally devoid of this
process. The extremely high level of HBsAg synthesis in
insect cells with the baculovirus expression vector system
may have surpassed the capacity for any cell type to produce
lipoprotein particles, so that it became a rate-limiting step. A
second block in the secretory process occurred at the level
of transport of lipoprotein particles through the cellular
secretory pathway. HBsAg synthesized in mammalian
(CHO) cells also appears to accumulate in the ER prior to
transport to the Golgi, since essentially all of the intracellular
HBsAg is endo H sensitive and the half-time for secretion is
unusually long (37, 38). Under certain conditions, low levels
of HBsAg have been detected in the medium of infected
insect cultures. The detection of HBsAg in the medium was
highly erratic, and what was detected was probably the
result of cell death. In a recent report, Kang and co-workers
(19) suggested that insect cells could secrete HBsAg when
grown in spinner culture but not when grown as adherent
cells. Insect cells can be readily grown in spinner culture,
but considerable caution is required to prevent cell rupture
in the late stages of infection, when the cells become very
fragile. We have been unable to detect a significant level of
HBsAg secretion in spinner culture when sufficient care was
used.
Despite the lack of secretion, the level of processing of
HBsAg observed in insect cells is substantially better than in
yeast cells. The S protein is not glycosylated in yeast cells (6,
14, 30, 33, 57, 61), and the limited amount of particle
formation that has been detected may represent an artifact of
the extraction process (6). The lack of particle formation
with the pre-S-S polypeptides with a fractionation procedure
identical to that used for S suggests that particle formation is
not occurring during extraction in our system. Inefficient
secretion of HBsAg has been observed in other cell systems
as well. Following infection of monkey kidney cells with
recombinant SV40 (35) and adenoviruses (5) that express
HBsAg, 60 and 22% of the HBsAg remained cell associated,
respectively. Even in CHO cells, in which secretion of
HBsAg is considered efficient, 22 h is required to completely
secrete newly synthesized HBsAg (37). Only 2.5% of the S
protein synthesized in Xenopus oocytes was secreted during
a 48-h period (50). In Xenopus oocytes, the major block in
secretion of HBsAg appears to be a defect in the formation
of soluble lipoprotein particles in the lumen of the ER (45).
The exceptionally low level of secretion of the S protein
observed in Xenopus oocytes and insect cells may be attrib-
utable to the reduced temperatures at which these cells must
be maintained. However, the efficient secretion of HBsAg
may be a property unique to the differentiated hepatocyte,
which is dedicated to the production of serum lipoprotein
particles.
The lack of secretion initially presented a major problem
in the purification of HBsAg from insect cells. This problem
was overcome by detergent extraction and affinity purifica-
tion, in which HBsAg was purified to near homogeneity in
a single step. Although detergent extraction disrupts the
HBsAg lipoprotein particles, HBsAg readily forms micelles
following detergent treatment, and the resulting HBsAg
detergent micelles are highly antigenic and immunogenic in
comparison to HBsAg lipoprotein particles (16, 46, 47). The
reactivity of our purified material was comparable to that of
plasma-derived HBsAg, as evaluated by a commercial
HBsAg assay, and was highly effective when used as a solid
phase for anti-HBsAg assays as well. The baculovirus-
derived HBsAg induced a vigorous in vivo immune response
in mice. The specificity of the immune response to insect
cell-derived HBsAg in comparison to the response against
plasma-derived HBsAg is currently under further investiga-
tion.
A recombinant baculovirus was also constructed that
expressed the pre-S-S gene open reading frame. The current
data would suggest that the pre-S-S polypeptides (p39 and
gp42) are modified in an identical manner in insect and
mammalian cells, including insertion into the ER, glycosyl-
ation, myristylation (40), and lack of secretion (3, 4, 31, 35,
39). The use of insect cells offers a unique advantage over
mammalian cells because pre-S-S can be expressed in the
absence of the S polypeptide due to the inability of insect
cells to recognize the S promoter that is within the pre-S
coding domain.
The level of HBsAg synthesis attained by using the
baculovirus expression vector system was exceedingly high.
The system promises to be one of the most cost-effective
means for producing recombinant antigens. The improve-
ment of expression vectors and culture conditions should
yield even higher levels of synthesis. During the course of
this investigation, the importance of sequences immediately
5' to the polyhedrin ATG initiation codon became apparent
(25, 28, 29). The expression of HBsAg was approximately
15-fold lower with the recombinant virus 373S (6 mg/liter of
cells) than with 106FS (90 mg/liter). The vector pAc373 is
missing an AT-rich stretch from nucleotides -8 to -1 with
respect to the polyhedrin initiation codon (Fig. 1), while the
fusion vector pVL106 contains an intact 5' untranslated
region (28). Analysis of HBsAg mRNA levels revealed that
the differences in the level of protein expression were
directly proportional to the amount of HBsAg-specific
mRNA detected in 373S- and 106FS-infected cells (25). The
sequences immediately upstream of the polyhedrin initiation
codon are apparently crucial for maximum transcriptional
activity from this promoter. A series of nonfusion vectors
have been constructed in which the 5' untranslated region
remains intact and the initiation codon has been altered to
prevent the synthesis of a fusion protein (V. Luckow,
manuscript submitted). We recently used one of these vec-
tors (pVL941) for the expression ofSV40 large T antigen (23)
and HBsAg and obtained levels of recombinant antigen
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comparable to those obtained with the fusion vectors. The
use of these vectors will greatly increase the yield of
recombinant protein in future investigations with the bacu-
lovirus expression vector system.
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